Insmed Incorporated (INSM)

Healthcare · Biotechnology · NASDAQ

Insmed Incorporated (INSM) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $28.63B and a free-cash-flow yield of -3.7%. Over the most recent reported fiscal year, revenue grew 66.7%.

Market cap	$28.63B
Trailing P/E	—
FCF yield	-3.7%
Revenue growth (YoY)	+66.7%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live INSM data on Nama Insights →

Recent Congressional trades

Insmed Incorporated trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Josh Gottheimer	House	Buy	$1,001 - $15,000	Jul 7, 2025